Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term

Robert J. McDonald, Jeffrey C. Weinreb, Matthew S. Davenport

Research output: Contribution to journalArticlepeer-review


In this article, members of the American College of Radiology Committee on Drugs and Contrast Media propose a new term for symptoms reported after intravascular exposure to gadolinium-based contrast agents-Symptoms Associated with Gadolinium Exposure, or SAGE. This term is advocated in lieu of other proposed nomenclature that presumes a causal relationship that has not yet been scientifically verified. The purpose of this new term, SAGE, is to assist researchers and clinical providers in describing such symptoms without prematurely causally attributing them to a disease and to standardize reporting of these symptoms to allow for coherent interpretation of related studies.

Original languageEnglish (US)
Pages (from-to)270-273
Number of pages4
Issue number2
StatePublished - Feb 2022

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term'. Together they form a unique fingerprint.

Cite this